Ireland - English - HPRA (Health Products Regulatory Authority)

geigy pharmaceuticals - phenylbutazone prednisone - tablets

Ireland - English - HPRA (Health Products Regulatory Authority)

ciba geigy plc - phenylbutazone - tablets - 100 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ciba geigy plc - phenylbutazone - tablets - 200 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

geigy pharmaceuticals - phenylbutazone - tablets

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - phenylbutazone 100mg - enteric coated tablet - 100 mg - active: phenylbutazone 100mg excipient: ammonia colloidal silicon dioxide dispersed blue 70878 gelatin hypromellose silicone antifoam emulsion. se2 macrogol 6000 macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer methylated spirits microcrystalline cellulose polyethylene glycol hydrogenated castor oil povidone purified talc   purified water   sodium starch glycolate stearic acid sucrose titanium dioxide

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. na - not available a depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology : 17th revised edition . ny, ny: ardent media, inc., 1998. combination oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. thrombogenic valvulopathies

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw) - aubra is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and norplant® system, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. emergency contraceptive pills: the fda has concluded that certain combined oral contraceptives containing ethinyl estradiol and norgestrel or levonorgestrel are safe and effective for use as postcoital emergency contraception. treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.9 lactation amenorrhea method: lam is a highly effective, temporary method of contraception.10 source: trussell j. contraceptive efficacy. in: hatcher ra,

Ireland - English - HPRA (Health Products Regulatory Authority)

geigy pharmaceuticals - phenylbutazone - suppositories - 250 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

geigy pharmaceuticals - phenylbutazone lidocaine -

United States - English - NLM (National Library of Medicine)

glenmark generics inc., usa - norgestimate (unii: c291hfx4dy) (norgestimate - unii:c291hfx4dy), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norgestimate 0.25 mg - norgestimate and ethinyl estradiol tablets usp are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective for pregnancy prevention. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. method typical use§ perfect use¶ norgestimate and ethinyl estradiol tablets usp have not been studied for and are not indicated for use in emergency contraception. in clinical trials with norgestimate and ethinyl estradiol tablets, 1,651 subjects completed 24,272 cycles and the overall use-efficacy (typical user efficacy) pregnancy rate was approximately 1 pregnancy per 100 women-years. this rate includes patients who d